Subsequently, the loss-of-function investigation revealed that GSG2 knockdown inhibited bladder cancer development in vitro and in vivo, which may be derived from the regulation of cell apoptosis and cell cycle distribution. The gene discussed is HASPIN; the disease is urinary bladder cancer.